Mivavotinib for relapsed/refractory B-cell lymphoma

by Impact Journals LLCKaplan–Meier curve for estimated median DOR in the DLBCL combined cohort (response-evaluable population). Credit: 2023 Gordon et al.In a new research paper published inOnco

Updated on: January 02,2024

Mivavotinib for relapsed/refractory B-cell lymphoma

by Impact Journals LLCKaplan–Meier curve for estimated median DOR in the DLBCL combined cohort (response-evaluable population). Credit: 2023 Gordon et al.In a new research paper published inOnco

Updated on:January 02,2024

Branched-chain amino acids regulate the development and progression of cancer

by Agency for Science, Technology and Research (A*STAR), SingaporeFigure 1. Credit: Agency for Science, Technology and Research (A*STAR), SingaporeResearchers at A*STAR's Singapore Bioimaging

Updated on: April 14,2024

Branched-chain amino acids regulate the development and progression of cancer

by Agency for Science, Technology and Research (A*STAR), SingaporeFigure 1. Credit: Agency for Science, Technology and Research (A*STAR), SingaporeResearchers at A*STAR's Singapore Bioimaging

Updated on:April 14,2024

Are 3-D mammograms really better? US puts scans to the test

by Lauran NeergaardIn this Nov. 21, 2017 photo provided by the Montefiore Health System, Dr. Tova Koenigsberg at The Montefiore Einstein Center for Cancer Care in New York shows an example of a tradit

Updated on: March 14,2024

Are 3-D mammograms really better? US puts scans to the test

by Lauran NeergaardIn this Nov. 21, 2017 photo provided by the Montefiore Health System, Dr. Tova Koenigsberg at The Montefiore Einstein Center for Cancer Care in New York shows an example of a tradit

Updated on:March 14,2024

Study finds racial disparities in culturally competent cancer care

by Dana-Farber Cancer InstituteBrandon A. Mahal, MD of Dana-Farber Cancer Institute, co-senior author of the study published inJAMA Oncology. Credit: Dana-Farber Cancer InstituteMany non-wh

Updated on: July 04,2024

Study finds racial disparities in culturally competent cancer care

by Dana-Farber Cancer InstituteBrandon A. Mahal, MD of Dana-Farber Cancer Institute, co-senior author of the study published inJAMA Oncology. Credit: Dana-Farber Cancer InstituteMany non-wh

Updated on:July 04,2024

Study identifies how cancer-causing gene regulates genetic variation in prostate cancer

by Queen Mary, University of LondonGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111404Researchers from Barts Cancer Institute (BCI) at Queen Mary Universi

Updated on: January 30,2024

Study identifies how cancer-causing gene regulates genetic variation in prostate cancer

by Queen Mary, University of LondonGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111404Researchers from Barts Cancer Institute (BCI) at Queen Mary Universi

Updated on:January 30,2024

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on: January 07,2024

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on:January 07,2024

Researchers identify compounds that starve melanoma cancer cells of energy

by Oregon State UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Researchers at Oregon State University a

Updated on: June 19,2024

Researchers identify compounds that starve melanoma cancer cells of energy

by Oregon State UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Researchers at Oregon State University a

Updated on:June 19,2024

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on: February 18,2024

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on:February 18,2024

Study finds that trust in cancer information declined among Black Americans during the pandemic

byTaylor & FrancisCredit: Unsplash/CC0 Public DomainTrust in information given out by the government on cancer fell sharply among the Black population—by almost half—during the COVID-19 pand

Updated on: January 23,2024

Study finds that trust in cancer information declined among Black Americans during the pandemic

byTaylor & FrancisCredit: Unsplash/CC0 Public DomainTrust in information given out by the government on cancer fell sharply among the Black population—by almost half—during the COVID-19 pand

Updated on:January 23,2024

Early onset colorectal cancer rising fastest in the west

by American Cancer SocietyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Early-onset colorectal cancer -cancer occurring before age 50—is rising most rapidly in

Updated on: April 20,2024

Early onset colorectal cancer rising fastest in the west

by American Cancer SocietyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Early-onset colorectal cancer -cancer occurring before age 50—is rising most rapidly in

Updated on:April 20,2024

Diagnostic performance of contrast-enhanced ultrasound using perfluorobutane for high-risk hepatocellular carcinoma

byAmerican Roentgen Ray Society(A) Arterial-phase CEUS image (12 seconds after injection) shows 25-mm segment-8 lesion with nonrim hyperenhancement (arrow). (B) CEUS image in portal-venous phase

Updated on: January 02,2024

Diagnostic performance of contrast-enhanced ultrasound using perfluorobutane for high-risk hepatocellular carcinoma

byAmerican Roentgen Ray Society(A) Arterial-phase CEUS image (12 seconds after injection) shows 25-mm segment-8 lesion with nonrim hyperenhancement (arrow). (B) CEUS image in portal-venous phase

Updated on:January 02,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on: January 22,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on:January 22,2024